[Group B streptococci as a cause of neonatal infections in humans: epidemiology, pathogenesis, clinical features, treatment and prophylaxis]

Akush Ginekol (Sofiia). 2013;52(3):55-60.
[Article in Bulgarian]

Abstract

This paper aims to draw the attention of Bulgarian gynecologists, pediatricians, microbiologists on group B streptococci as a cause of serious invasive neonatal diseases associated with high mortality rate or disability. Epidemiology, pathogenesis and clinical features of the infection are described. Data on the antibiotic susceptibility and recommendations for treatment are presented. The main purpose of the paper is to lay particular stress on the importance of intrapartum antibiotic prophylaxis for pregnant women who are positive for rectovaginal group B streptococcal colonization. This measure was introduced in the USA (guidelines from 1996, 2002, 2010 years), it proved its efficacy and now a lot of the European countries put efforts to adopt it in their health-care system.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antibiotic Prophylaxis
  • Female
  • Humans
  • Immunotherapy, Active
  • Infant, Newborn
  • Infant, Newborn, Diseases / drug therapy*
  • Infant, Newborn, Diseases / epidemiology
  • Infant, Newborn, Diseases / pathology
  • Infant, Newborn, Diseases / prevention & control
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / epidemiology
  • Pregnancy Complications, Infectious / pathology
  • Pregnancy Complications, Infectious / prevention & control
  • Streptococcal Infections / drug therapy*
  • Streptococcal Infections / epidemiology
  • Streptococcal Infections / pathology
  • Streptococcal Infections / prevention & control
  • Streptococcus / isolation & purification*
  • Streptococcus / pathogenicity

Substances

  • Anti-Bacterial Agents